Reshma Kewalramani - Sep 30, 2022 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Director
Signature
/s/ Karen Tepichin, Attorney-in-Fact
Stock symbol
DNA
Transactions as of
Sep 30, 2022
Transactions value $
$0
Form type
4
Date filed
11/10/2022, 04:30 PM
Previous filing
Aug 17, 2022
Next filing
Jan 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNA Class A Common Stock Options Exercise +9.82K +13.84% 80.7K Sep 30, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Restricted Stock Units Options Exercise $0 -9.82K -100% $0.00* 0 Sep 30, 2022 Class A Common Stock 9.82K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the conversion of restricted stock units ("RSUs") into Class A common stock.
F2 Each RSU represents a contingent right to receive one share of Class A common stock.
F3 In accordance with an agreement between the Reporting Person and the issuer to delay vesting of the RSUs, the RSUs vested on September 30, 2022.